STAAR Surgical Company (STAA)

STAAR Surgical’s second fiscal quarter of 2026 paired a revenue beat with an EPS miss, as results reported August 12, 2026 showed revenue of $93.5 million topped the $90.6 million estimate (+3.2%) while EPS of $0.16 trailed the $0.22 estimate (-28%). Revenue rose 111% to about $93.5 million, up from about $44.3 million a year ago, alongside a swing in per-share results from -$0.34 a year ago. Profitability came through at a gross margin of roughly 75% and an operating margin near 11%, with gross profit of about $69.7 million and operating income of roughly $10.1 million. The quarter generated operating cash flow of about $19.7 million, and the company repurchased roughly $2.7 million of stock. For the next period, consensus calls for EPS of $0.20 on revenue of $79.1 million.